These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 11682445

  • 1. Renoprotective effects of carvedilol in hypertensive-stroke prone rats may involve inhibition of TGF beta expression.
    Wong VY, Laping NJ, Nelson AH, Contino LC, Olson BA, Gygielko E, Campbell WG, Barone F, Brooks DP.
    Br J Pharmacol; 2001 Nov; 134(5):977-84. PubMed ID: 11682445
    [Abstract] [Full Text] [Related]

  • 2. Chronic carvedilol reduces mortality and renal damage in hypertensive stroke-prone rats.
    Barone FC, Nelson AH, Ohlstein EH, Willette RN, Sealey JE, Laragh JH, Campbell WG, Feuerstein GZ.
    J Pharmacol Exp Ther; 1996 Nov; 279(2):948-55. PubMed ID: 8930204
    [Abstract] [Full Text] [Related]

  • 3. Chimeric DNA-RNA hammerhead ribozyme targeting transforming growth factor-beta1 mRNA ameliorates renal injury in hypertensive rats.
    Tahira Y, Fukuda N, Endo M, Ueno T, Matsuda H, Saito S, Matsumoto K, Mugishima H.
    J Hypertens; 2007 Mar; 25(3):671-8. PubMed ID: 17278984
    [Abstract] [Full Text] [Related]

  • 4. Carvedilol prevents and reverses hypertrophy-induced cardiac dysfunction.
    Barone FC, Willette RN, Nelson AH, Ohlstein EH, Brooks DP, Coatney RW.
    Pharmacology; 2007 Mar; 80(2-3):166-76. PubMed ID: 17551266
    [Abstract] [Full Text] [Related]

  • 5. [Effect of perindopril on renal interstitial fibrosis of hypertension in rats].
    Xu H, Tao LJ, Sun M.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Feb; 29(1):61-4. PubMed ID: 16137008
    [Abstract] [Full Text] [Related]

  • 6. Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats.
    Chung S, Park CW, Shin SJ, Lim JH, Chung HW, Youn DY, Kim HW, Kim BS, Lee JH, Kim GH, Chang YS.
    Nephrol Dial Transplant; 2010 Feb; 25(2):389-99. PubMed ID: 19749146
    [Abstract] [Full Text] [Related]

  • 7. Chronic treatment with losartan and carvedilol differentially modulates renal vascular responses to sympathomimetics compared to treatment with individual agents in normal Wistar Kyoto and spontaneously hypertensive rats.
    Abdulla MH, Sattar MA, Abdullah NA, Khan MA, Abdallah HH, Johns EJ.
    Eur J Pharmacol; 2009 Jun 10; 612(1-3):69-74. PubMed ID: 19356722
    [Abstract] [Full Text] [Related]

  • 8. Effect of carvedilol on pulse pressure and left ventricular hypertrophy in spontaneously hypertensive rats with adriamycin nephropathy.
    Jovanovic D, Jovovic D, Mihailovic-Stanojevic N, Miloradovic Z, Naumovic R, Dimitrijevic J, Maksic N, Djukanovic L.
    Biomed Pharmacother; 2009 Sep 10; 63(8):571-6. PubMed ID: 19013753
    [Abstract] [Full Text] [Related]

  • 9. The role of bradykinin B1 receptor on cardiac remodeling in stroke-prone spontaneously hypertensive rats (SHR-SP).
    Moniwa N, Agata J, Hagiwara M, Ura N, Shimamoto K.
    Biol Chem; 2006 Feb 10; 387(2):203-9. PubMed ID: 16497153
    [Abstract] [Full Text] [Related]

  • 10. Renoprotective effects of an angiotensin II receptor blocker in experimental model rats with hypertension and metabolic disorders.
    Watanabe D, Tanabe A, Naruse M, Morikawa S, Ezaki T, Takano K.
    Hypertens Res; 2009 Sep 10; 32(9):807-15. PubMed ID: 19662019
    [Abstract] [Full Text] [Related]

  • 11. Renal protective effect of TCV-116 in stroke-prone spontaneously hypertensive rats.
    Kim S, Ohta K, Hamaguchi A, Omura T, Yukimura T, Miura K, Inada Y, Wada T, Ishimura Y, Chatani F.
    Blood Press Suppl; 1994 Sep 10; 5():54-6. PubMed ID: 7889201
    [Abstract] [Full Text] [Related]

  • 12. Potentiation of natriuretic peptide action by the beta-adrenergic blocker carvedilol in hypertensive rats: a new antihypertensive mechanism.
    Yoshimoto T, Naruse M, Tanabe A, Naruse K, Seki T, Imaki T, Muraki T, Matsuda Y, Demura H.
    Endocrinology; 1998 Jan 10; 139(1):81-8. PubMed ID: 9421401
    [Abstract] [Full Text] [Related]

  • 13. Pre-weaning carvedilol treatment in spontaneously hypertensive rats.
    Boesen EI, Lambert GW, Anderson WP, Kett MM.
    Eur J Pharmacol; 2004 Feb 20; 486(2):183-8. PubMed ID: 14975707
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of Rho-kinase attenuates nephrosclerosis and improves survival in salt-loaded spontaneously hypertensive stroke-prone rats.
    Nishikimi T, Koshikawa S, Ishikawa Y, Akimoto K, Inaba C, Ishimura K, Ono H, Matsuoka H.
    J Hypertens; 2007 May 20; 25(5):1053-63. PubMed ID: 17414670
    [Abstract] [Full Text] [Related]

  • 15. Transforming growth factor-beta expression in cardiovascular organs in stroke-prone spontaneously hypertensive rats with the development of hypertension.
    Tahira Y, Fukuda N, Endo M, Suzuki R, Ikeda Y, Takagi H, Matsumoto K, Kanmatsuse K.
    Hypertens Res; 2002 Nov 20; 25(6):911-8. PubMed ID: 12484516
    [Abstract] [Full Text] [Related]

  • 16. Adrenaline in cardiovascular diseases--effect of beta-adrenoceptor antagonists.
    Dehner R, Ikeda K, Yamori Y, Grobecker H.
    Z Kardiol; 1990 Nov 20; 79 Suppl 3():79-88. PubMed ID: 1983053
    [Abstract] [Full Text] [Related]

  • 17. The angiotensin type 1 receptor antagonist, eprosartan, attenuates the progression of renal disease in spontaneously hypertensive stroke-prone rats with accelerated hypertension.
    Abrahamsen CT, Barone FC, Campbell WG, Nelson AH, Contino LC, Pullen MA, Grygielko ET, Edwards RM, Laping NJ, Brooks DP.
    J Pharmacol Exp Ther; 2002 Apr 20; 301(1):21-8. PubMed ID: 11907153
    [Abstract] [Full Text] [Related]

  • 18. Carvedilol prevents severe hypertensive cardiomyopathy and remodeling.
    Barone FC, Campbell WG, Nelson AH, Feuerstein GZ.
    J Hypertens; 1998 Jun 20; 16(6):871-84. PubMed ID: 9663928
    [Abstract] [Full Text] [Related]

  • 19. Alteration of renal adrenomedullin and its receptor system in the severely hypertensive rat: effect of diuretic.
    Nishikimi T, Wang X, Akimoto K, Tadokoro K, Mori Y, Ishikawa Y, Ishimura K, Yoshihara F, Minamino N, Kangawa K, Matsuoka H.
    Regul Pept; 2005 Jan 15; 124(1-3):89-98. PubMed ID: 15544845
    [Abstract] [Full Text] [Related]

  • 20. Tranilast prevents the progression of experimental diabetic nephropathy through suppression of enhanced extracellular matrix gene expression.
    Akahori H, Ota T, Torita M, Ando H, Kaneko S, Takamura T.
    J Pharmacol Exp Ther; 2005 Aug 15; 314(2):514-21. PubMed ID: 15857946
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.